Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 582–588 | Cite as

α1-Adrenoceptors of rat myocardium: Comparison of agonist binding and positive inotropic response

  • Gerhard Groß
  • Gertraud Hanft
  • Christian-U. Rugevics
Article

Summary

Binding of agonists to al-adrenoceptors labelled by 3H-prazosin was investigated in membranes of rat myocardium and compared to the inotropic response elicited by α1-adrenoceptor activation on isolated right ventricles.
  1. 1.

    At 30°C the full agonists, adrenaline and phenylephrine, displaced 3H-prazosin with a shallow inhibition curve. The data are compatible with the assumption that 32% of the binding sites were in a state of high affinity for the agonist adrenaline (KI 85 nmol/l) and 68% in a low affinity state (KI I738 nmol/l). GTP transformed all binding sites into the low affinity form suggesting that at least some of the cardiac α1-adrenoceptors are coupled to N-proteins.

     
  2. 2.

    At 0°C most of the binding sites (86%) were in a state of high affinity for agonists (KI for adrenaline: 91 nmol/l).

     
  3. 3.

    For several partial agonists and antagonists (cirazoline, methoxamine, indanidine (Sgd 101-75), oxymetazoline and phentolamine) no such distinct temperature- and GTP-shifts could be demonstrated suggesting a different kind of interaction with al-binding sites.

     
  4. 4.

    When temperature was changed during incubation with adrenaline, a rise of temperature (from 0°C to 30°C) converted high affinity sites into the low affinity form, whereas a decrease in temperature (from 30°C to 0°C) failed to induce the high affinity state for agonists. Short term incubation (0.5 min) with adrenaline at 30°C resulted in significantly lower IC50 values as compared to equilibrium conditions at the same temperature.

     
  5. 5.

    Occupancy of al-adrenoceptor binding sites with adrenaline at O°C but not at 30°C rather closely paralleled the concentration-response curve for the α1-mediated increase in ontractile force.

     
  6. 6.

    Irreversible blockade of α1-adrenoceptors with phenoxybenzamine decreased the maximum inotropic response but only slightly affected pD2 values for the α1-stimulant effect of adrenaline.

     

Our binding experiments suggest that myocardial α1-adrenoceptors can exist in states of different affinity for agonists. Some agonists like adrenaline and phenylephrine seem to induce a temperature-dependent change in the conformation of the receptor which may represent a rapid form of desensitization. Since no appreciable receptor reserve was detected it is hypothesized that the high affinity state which can be measured at 0°C under equilibrium conditions may be relevant to the initiation of the functional response.

Key words

Cardiac α1-adrenoceptors 3H-Prazosin binding Positive inotropic effect Temperature sensitivity Receptor desensitization 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barlow RB (1983) Biodata handling with microcomputers. Elsevier, AmsterdamGoogle Scholar
  2. Benfey MD (1987) Function of myocardial α-adrenoceptors. J Appl Cardiol 2:49–70Google Scholar
  3. Böhm M, Mende U, Schmitz W, Scholz H (1986) Increased responsiveness to stimulation of a- but not β-adrenoceptors in the hereditary cardiomyopathy of the Syrian hamster. Intact adenosine- and cholinoceptor-mediated isoprenaline antagonistic effect. Eur J Pharmacol 128:195–203CrossRefGoogle Scholar
  4. Brückner R, Mügge A, Scholz H (1985) Existence and functional role of α1-adrenoceptors in the mammalian heart. J Mol Cell Cardiol 17:639–645CrossRefGoogle Scholar
  5. Buxton IL, Brunton LL (1986) α-Adrenergic receptors on rat ventricular myocytes: Characteristics and linkage to CAMP metabolism. Am J Physiol 251:H307–313PubMedGoogle Scholar
  6. Cheng Y, Prusoff WM (1973) Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108CrossRefGoogle Scholar
  7. Clark MG, Patten GS, Filsell OH (1982) Evidence for an α-adrenergic receptor-mediated control of energy production in heart. J Mol Cell Cardiol 14:313–321CrossRefGoogle Scholar
  8. Contreras ML, Wolfe BB, Molinoff PB (1986a) Thermodynamic properties of agonist interactions with the beta-adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound β-adrenergic receptors. J Pharmacol Exp Ther 237:154–164PubMedGoogle Scholar
  9. Contreras ML, Wolfe BB, Molinoff PB (1986b) Thermodynamic properties of agonist interactions with the beta-adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta-adrenergic receptors. J Pharmacol Exp Ther 237:165–172PubMedGoogle Scholar
  10. Colucci WS, Gimbrone MA Jr, Alexander R (1984) Regulation of myocardial and vascular α-adrenergic receptor affinity. Circulation Res 55:78–88CrossRefGoogle Scholar
  11. GroB G, Lues I (1985) Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 329:427–439CrossRefGoogle Scholar
  12. GrosB G, Hanft G (1988) 5-Methyl-urapidil — an antagonist which discriminates between α1-adrenoceptor subtypes. Br J Pharmacol, Proceedings Suppl (in press)Google Scholar
  13. Groß G, Hanft G, Rugevics C (1988) 5-Methyl-urapidil discriminates between subtypes of the α1-adrenoceptor. Eur J Pharmacol 151:333–335CrossRefGoogle Scholar
  14. Han C, Abel PW, Minneman KP (1987a) α1-Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature 329:333–335CrossRefGoogle Scholar
  15. Han C, Abel PW, Minneman KP (1987b) Heterogeneity of α1-adrenergic receptors revealed by chlorethylclonidine. Mol Pharmacol 32:505–510PubMedGoogle Scholar
  16. Hieble JP, Matthews WD, DeMarinis RM, Ruffolo RR Jr (1987) Heterogeneity of alpha-1 adrenergic receptors. In: Ruffolo RR Jr (ed) The alpha-1 adrenergic receptors. The Humana Press, Clifton, pp 325–349CrossRefGoogle Scholar
  17. Hoyer D, Reynolds EE, Molinoff PB (1984) Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol 25:209–218PubMedGoogle Scholar
  18. Ishac EJN, Pennefather JN, Handberg GM (1983) Effect of changes in thyroid state on atrial α- and β-adrenoceptors, adenylate cyclase activity, and catecholamine levels in the rat. J Cardiovasc Pharmacol 5:396–405CrossRefGoogle Scholar
  19. Jackson CV, McGrath GM, McNeill JH (1986) Alterations in alpha1 -adrenoceptor stimulation of isolated atria from experimental diabetic rats. Can J Physiol Pharmacol 64:145–151CrossRefGoogle Scholar
  20. Karliner JS, Barnes P, Brown M, Dollery C (1980) Chronic heart failure in the guinea pig increases cardiac α1- and β-adrenoceptors. Eur J Pharmacol 67:115–118CrossRefGoogle Scholar
  21. Kunos G, Mucci L, O'Regan S (1980) The influence of hormonal neuronal factors on rat heart adrenoceptors. Br J Pharmacol 71:371–386CrossRefGoogle Scholar
  22. Lynch CJ, Charest R, Blackmore PF, Exton JH (1985) Studies on the hepatic α1-adrenergic receptor. Modulation of guanine nucleotide effects by calcium, temperature, and age. J Biol Chem 260:1593–1600PubMedGoogle Scholar
  23. Lynch CJ, Taylor SJ, Smith JA, Exton JH (1988) Formation of the high-affinity agonist state of the a,-adrenergic receptor at cold temperatures does not require a G-protein. FEBS Lett 229:54–58CrossRefGoogle Scholar
  24. Maisel AS, Motulsky HJ, Ziegler MG, Insel PA (1987) Ischemia-and agonist-induced changes in a- and β-adrenergic receptor traffic in guinea pig hearts. Am J Physiol 253:H1159–1166PubMedGoogle Scholar
  25. McGrath J, Wilson V (1988) α1-Adrenoceptor subclassification by classical and response-related methods: Same question, different answers. Trends Pharmacol Sci 9:162–165CrossRefGoogle Scholar
  26. McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Computer Progr Biomed 17:107–113CrossRefGoogle Scholar
  27. Meidell RS, Sen A, Henderson SA, Slahetka MF, Chenn KR (1986) α1-Adrenergic stimulation of rat myocardial cells increases protein synthesis. Am J Physiol 251:H1076–1084PubMedGoogle Scholar
  28. Morrow AL, Creese I (1986) Characterization of α1-adrenergic receptor subtypes in rat brain: A reevaluation of 3H-WB4101 and 3H-prazosin binding. Mol Pharmacol 29:321–330PubMedGoogle Scholar
  29. Motulsky HJ, Cunningham EMS, Deblasi A, Inset PA (1986) Desensitization and redistribution of β-adrenergic receptors on human mononuclear leukocytes. Am J Physiol 250:E583–590PubMedGoogle Scholar
  30. Nakashima M, Hagino Y (1972) Evidence for the existence of alpha-adrenergic receptor in isolated rat atria. Jpn J Pharmacol 22:227–233CrossRefGoogle Scholar
  31. Otani H, Otani H, Das DK (1988) α1-Adrenoceptor-mediated phosphoinositide breakdown and isotropic response in rat left ventricular papillary muscles. Circ Res 62:8–17CrossRefGoogle Scholar
  32. Schwarz KR, Lanier SM, Carter EA, Graham RM, Homey CJ (1985) Transient high-affinity binding of agonists to α1-adrenergic receptors of intact liver cells. FEBS Lett 187:205–210CrossRefGoogle Scholar
  33. Schwarz KR, Lanier SM, Sena LM, Carter EA, Graham RM, Homey CJ (1986) Agonist-induced isomerisation of the α1-adrenergic receptor: Kinetic analysis using broken-cell and solubilized preparations. Biochem 25:2697–2702CrossRefGoogle Scholar
  34. Schümann HJ (1983) What role do α1- and β-adrenoceptors play in the regulation of the heart. Eur Heart J 4:55–60CrossRefGoogle Scholar
  35. Snavely MD, Mahan LC, O'Connor DT, Insel PA (1983) Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma. Endocrinology 113:354–361CrossRefGoogle Scholar
  36. Stiles GL, Hoffman BB, Hubbard M, Caron MG, Lefkowitz RJ (1983) Guanine nucleotides and al-adrenergic receptors in the heart. Biochem Pharmacol 32:69–71CrossRefGoogle Scholar
  37. Testa B, Jenner P, Kilpatrick DJ, El Tayar N, Van de Waterbeemd H, Marsden CD (1987) Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors? Biochem Pharmacol 36:4041–4046CrossRefGoogle Scholar
  38. Toews ML, Harden TK, Perkins JP (1983) High-affinity binding of agonists to β-adrenergic receptors on intact cells. Proc Natl Acad Sci USA 80:3553–3557CrossRefGoogle Scholar
  39. Weiland GA, Minneman KP, Molinoff PB (1979) Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor. Nature 281:114–117CrossRefGoogle Scholar
  40. Yamada S, Yamamura HI, Roeske WR (1982) An increase in cardiac α1-adrenoceptors following chronic clonidine treatment. Naunyn-Schmiedeberg's Arch Pharmacol 320:115–118CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Gerhard Groß
    • 1
  • Gertraud Hanft
    • 1
  • Christian-U. Rugevics
    • 1
  1. 1.Pharmakologisches Institut des Universitätsklinikums EssenEssen 1Germany

Personalised recommendations